Emerging evidence has exhibited that multi-kinase inhibitors alone or synergistically used with HDAC inhibitors could suppress PDAC tumor growth (Dent et al. 2021; Yu et al. 2022). The gene discussed is HDAC9; the disease is neoplasm.